Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis

被引:9
作者
Tong, Huan [1 ]
Gan, Can [2 ]
Wei, Bo [1 ]
Wang, Zhi Dong [1 ]
Li, Xiao Dan [1 ]
Qian, Shuai Jie [2 ]
Huan, Hui [2 ]
Zhang, Lin Hao [1 ]
Yang, Zhu [2 ]
Chen, Yi Long [3 ,4 ]
Gu, Yong Hong [3 ,4 ]
Chen, Liu Xiang [2 ]
Yang, Yu Hang [2 ]
Wu, Hao [1 ]
Tang, Cheng Wei [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Gastroenterol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Sch Med, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Sch Med, West China Biomed Big Data Ctr, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, Med Big Data Ctr, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatic encephalopathy; liver cirrhosis; transjugular intrahepatic portosystemic shunt; risk factor; PORTAL-HYPERTENSION; AMMONIA LEVELS; BLOOD AMMONIA; TIPS; MANAGEMENT; HYDROTHORAX; ASSOCIATION; GUIDELINES; CONSENSUS; WORKSHOP;
D O I
10.1111/1751-2980.12957
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective This study aimed to determine the risk factors and establish a risk score for post-transjugular intrahepatic portosystemic shunt (TIPS) overt hepatic encephalopathy (OHE). Methods Altogether 299 and 62 cirrhotic patients receiving TIPS from January 2015 to March 2018 were divided into the derivation and validation cohorts, respectively. The data of the derivation cohort were analyzed for risk factors of post-TIPS OHE. A risk score was established from the derivation cohort and verified by the validation cohort. Results During a median follow-up of 112.6 weeks, 52 (17.4%) patients in the derivation cohort experienced post-TIPS OHE. Logistic regression showed that alcoholic cirrhosis (odds ratio [OR] 3.068, 95% confidence interval [CI] 1.423-6.613, P = 0.004), stent diameter of 10 mm (OR 12.046 [95% CI 2.308-62.862], P = 0.003), portal pressure gradient (PPG) decrement >= 60% (OR 3.548 [95% CI 1.741-7.230], P < 0.001), model for end-stage liver disease (MELD) score >= 10 (OR 2.695 [95% CI 1.203-6.035], P = 0.016), blood ammonia (OR 1.009 [95% CI 1.000-1.018], P = 0.043) and notable hydrothorax (OR 4.393 [95% CI 1.554-12.415], P = 0.005) were associated with an increased risk of post-TIPS OHE. The risk score reached a promising risk evaluation of post-TIPS OHE when verified by the validation cohort (sensitivity 71.4%, specificity 70.7%, accuracy 71.0%). Conclusions Alcoholic cirrhosis and notable hydrothorax are independent risk factors for post-TIPS OHE in liver cirrhosis, together with the stent diameter of 10 mm, PPG decrement >= 60%, MELD score >= 10 and blood ammonia. The established risk score is reliable to identify high-risk individuals of developing post-TIPS OHE.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [41] Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
    Riggio, O
    Masini, A
    Efrati, C
    Nicolao, F
    Angeloni, S
    Salvatori, FM
    Bezzi, M
    Attili, AF
    Merli, M
    JOURNAL OF HEPATOLOGY, 2005, 42 (05) : 674 - 679
  • [42] Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota
    Xu, Xiaotong
    Zhu, Tong
    Jing, Changyou
    Jiang, Minjie
    Fu, Yunlai
    Xie, Fang
    Meng, Qinghua
    Li, Jianjun
    FRONTIERS IN MEDICINE, 2025, 12
  • [43] High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation
    Kloster, Marie-Louise
    Ren, Albert
    Shah, Ketan Y.
    Alqadi, Murad M.
    Bui, James T.
    Lipnik, Andrew J.
    Niemeyer, Matthew M.
    Ray, Charles E.
    Gaba, Ron C.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (11) : 4058 - 4062
  • [44] Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
    Yin, Liang
    Chu, Sen-Lin
    Lv, Wei-Fu
    Zhou, Chun-Ze
    Liu, Kai-Cai
    Zhu, Yi-Jiang
    Zhang, Wen-Yue
    Wang, Cui-Xia
    Zhang, Yong-Hui
    Lu, Dong
    Cheng, De-Lei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (18) : 2875 - 2887
  • [45] No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    Riggio, Oliviero
    Nardelli, Silvia
    Pasquale, Chiara
    Pentassuglio, Ilaria
    Gioia, Stefania
    Onori, Eugenia
    Frieri, Camilla
    Salvatori, Filippo Maria
    Merli, Manuela
    METABOLIC BRAIN DISEASE, 2016, 31 (06) : 1275 - 1281
  • [46] MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation
    Song, Jinlei
    Wang, Xiaoze
    Yan, Yuling
    Xiang, Tong
    Luo, Xuefeng
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (07) : 3185 - 3192
  • [47] No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    Oliviero Riggio
    Silvia Nardelli
    Chiara Pasquale
    Ilaria Pentassuglio
    Stefania Gioia
    Eugenia Onori
    Camilla Frieri
    Filippo Maria Salvatori
    Manuela Merli
    Metabolic Brain Disease, 2016, 31 : 1275 - 1281
  • [48] Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement
    Nardelli, Silvia
    Lattanzi, Barbara
    Torrisi, Sabrina
    Greco, Francesca
    Farcomeni, Alessio
    Gioia, Stefania
    Merli, Manuela
    Riggio, Oliviero
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) : 934 - 936
  • [49] Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension Case series
    Zheng, Dan
    Yu, Jiao
    Li, Hui
    Gan, Hongying
    Wang, Jun
    Jiang, Ting
    Ren, Huanping
    Wu, Fan
    MEDICINE, 2021, 100 (27) : E26610
  • [50] Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension
    Wei, Jian
    Li, Honglu
    Li, Changqing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (04) : 826 - 832